BioChain’s CancerSeq formalin fixed paraffin embedded (FFPE) tissues are tumor tissues that have been prescreened extensively for single nucleotide polymorphisms (SNPs), insertions & deletions (indels), and copy number variations (CNVs). Targeted Next Generation Sequencing (NGS), using cancer gene panels, was performed to identify mutations and mutational hotspots. BioChain’s CancerSeq tissues are ideal for verification, genotyping, or identification of new mutational hotspots.
Need help with your order?
Find out more about placing an order here or contact us for technical support.
Pricing is for US customers only. For international pricing, please contact your local distributor. View Distributors Here.
To generate our CancerSeq line of tissues, genomic DNA was extracted from the FFPE tissues and validated by targeted NGS with Illumina’s TruSeq Amplicon - Cancer Panel (TSACP), which includes 48 cancer-related genes. Our prescreened tissues come with detailed information regarding donor and cancer type, as well as NGS information such as chromosomal position, variant type (SNP or indel), alternate allele variations, quality score, depth of coverage, allele type, transcript ID and more. We offer the prescreened tissue as mounted sections or whole block. Please inquire for other options, such as curls or extracted nucleic acids.
Looking for multiple donors or additional samples?